Company news
Fennec Pharmaceuticals Inc. news in 2026
Fennec Pharmaceuticals Inc.'s news releases, calls and decks from 2026, newest first.
Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026
September 17, 2026
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026
August 5, 2026
Fennec Pharmaceuticals Announces Inducement Grants under Nasdaq Listing Rule 5635(4)
June 16, 2026
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
June 15, 2026
Fennec Pharmaceuticals Announces Results of Annual Meeting
June 9, 2026
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
May 21, 2026
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
May 8, 2026
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
May 7, 2026
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
April 20, 2026
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
April 6, 2026
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 30, 2026
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 23, 2026
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026
March 17, 2026
Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation
March 15, 2026
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
March 4, 2026
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers
February 20, 2026
Calls in 2026
Decks in 2026
- Investor Presentation (August 2026)
Investor deck · 31 slides · August 2026